1st Quarter - Report

BIOMET, INC. for BIOMET, INC.

Period 1st Quarter 2013 Filed Apr 18, 2013 Signed by Millard P. Plumlee, Associate General Counsel, Biomet, Inc.

Official filing
Firm
BIOMET, INC.
Client
BIOMET, INC.
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 436 - Health Care Cost Reduction Act of 2012; S.17-Medical Device Access & Innovation Act; H.R. 523 - Protect Medical Innovation Act of 2013

LobbyistCovered position, as disclosed
WILLIAM C KOLTER —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 17 (113th), H.R. 523 (113th), H.R. 436 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.